iodixanol has been researched along with Angiogenesis, Pathologic in 4 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
| Excerpt | Relevance | Reference |
|---|---|---|
| "69 patients with metastatic renal cell carcinoma had dynamic contrast-enhanced CT scans at baseline and after 5 and 10 weeks of treatment." | 1.48 | Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients. ( Donskov, F; Madsen, HHT; Mains, JR; Pedersen, EM; Rasmussen, F; Thorup, K; Thygesen, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mains, JR | 1 |
| Donskov, F | 1 |
| Pedersen, EM | 1 |
| Madsen, HHT | 1 |
| Thygesen, J | 1 |
| Thorup, K | 1 |
| Rasmussen, F | 1 |
| Anemone, A | 1 |
| Consolino, L | 1 |
| Longo, DL | 1 |
| Chen, SC | 1 |
| Carton, AK | 1 |
| Albert, M | 1 |
| Conant, EF | 1 |
| Schnall, MD | 1 |
| Maidment, AD | 1 |
| Kagadis, GC | 1 |
| Spyridonos, P | 1 |
| Karnabatidis, D | 1 |
| Diamantopoulos, A | 1 |
| Athanasiadis, E | 1 |
| Daskalakis, A | 1 |
| Katsanos, K | 1 |
| Cavouras, D | 1 |
| Mihailidis, D | 1 |
| Siablis, D | 1 |
| Nikiforidis, GC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study[NCT01433640] | 30 participants (Actual) | Observational | 2011-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for iodixanol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.
Topics: Blood Flow Velocity; Blood Volume; Carcinoma, Renal Cell; Contrast Media; Four-Dimensional Computed | 2018 |
MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.
Topics: Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Image Enhancement; Iohexol; Iop | 2017 |
Initial clinical experience with contrast-enhanced digital breast tomosynthesis.
Topics: Adult; Breast Neoplasms; Contrast Media; Humans; Mammography; Middle Aged; Neovascularization, Patho | 2007 |
Computerized analysis of digital subtraction angiography: a tool for quantitative in-vivo vascular imaging.
Topics: Angiography, Digital Subtraction; Animals; Contrast Media; Disease Models, Animal; False Negative Re | 2008 |